Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
11501
CALL
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $78.1K | ﹤0.01% |
+1,400
| New | +$49.6K |
|
11502
PUT
ESAB
ESAB
$5.27B
| $78.1K | ﹤0.01% |
1,322
-593
| -31% | -$34K |
|
|
VLRS
11503
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $78.1K | ﹤0.01% |
6,276
+6,229
| +13,253% | +$68.9K |
|
|
ABCM
11504
CALL
DELISTED
Abcam PLC
ABCM
| $78.1K | ﹤0.01% |
5,800
+5,600
| +2,800% | +$83.6K |
|
|
SELF
11505
Global Self Storage
SELF
$61.1M
| $78.1K | ﹤0.01% |
15,188
-12,822
| -46% | -$67.2K |
|
11506
LifeVantage
LFVN
$82.9M
| $78K | ﹤0.01% |
21,720
-10,543
| -33% | -$39.6K |
|
11507
Focus Universal
FCUV
$3.95M
| $77.9K | ﹤0.01% |
+78
| New | +$113K |
|
11508
CALL
OmniAb
OABI
$491M
| $77.9K | ﹤0.01% |
21,180
-8,720
| -29% | -$32.9K |
|
|
CELL
11509
DELISTED
PhenomeX Inc. Common Stock
CELL
| $77.8K | ﹤0.01% |
67,104
-13,967
| -17% | -$25.5K |
|
|
ASTR
11510
CALL
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $77.7K | ﹤0.01% |
12,193
-2,114
| -15% | -$16.8K |
|
11511
CALL
Atea Pharmaceuticals
AVIR
$411M
| $77.7K | ﹤0.01% |
23,200
-46,200
| -67% | -$187K |
|
11512
PUT
Ribbon Communications
RBBN
$377M
| $77.6K | ﹤0.01% |
22,700
+22,500
| +11,250% | +$82.2K |
|
11513
CervoMed
CRVO
$41.3M
| $77.6K | ﹤0.01% |
+12,438
| New | +$110K |
|
11514
CALL
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $77.4K | ﹤0.01% |
800
-900
| -53% | -$85.8K |
|
11515
PUT
iShares MSCI China Small-Cap ETF
ECNS
$66.3M
| $77.3K | ﹤0.01% |
2,300
-6,000
| -72% | -$223K |
|
11516
CSX Corp
CSX
$92.9B
| $77.2K | ﹤0.01% |
2,579
-7,604,253
| -100% | -$234M |
|
|
ESMT
11517
CALL
DELISTED
EngageSmart, Inc.
ESMT
| $77K | ﹤0.01% |
4,000
-300
| -7% | -$5.8K |
|
|
CODX
11518
CALL
Co-Diagnostics
CODX
$9.77M
| $77K | ﹤0.01% |
1,733
-3,117
| -64% | -$250K |
|
|
PYCR
11519
CALL
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $76.9K | ﹤0.01% |
2,900
+1,300
| +81% | +$32.1K |
|
11520
CALL
IDEAYA Biosciences
IDYA
$3.49B
| $76.9K | ﹤0.01% |
5,600
-184,900
| -97% | -$3.08M |
|
11521
Aligos Therapeutics
ALGS
$43M
| $76.8K | ﹤0.01% |
3,515
+64
| +2% | +$2.44K |
|
11522
PUT
Cohen & Steers
CNS
$4.36B
| $76.8K | ﹤0.01% |
1,200
-100
| -8% | -$6.97K |
|
11523
PUT
German American Bancorp
GABC
$1.93B
| $76.8K | ﹤0.01% |
+2,300
| New | +$85.5K |
|
|
SOHU
11524
PUT
Sohu.com
SOHU
$378M
| $76.6K | ﹤0.01% |
5,200
-7,000
| -57% | -$105K |
|
11525
908 Devices
MASS
$414M
| $76.6K | ﹤0.01% |
8,906
-21,619
| -71% | -$193K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.